PremiumThe FlyClearmind announces publication of international patent application under PCT Clearmind receives approval for Phase 1/2a trial for AUD at Hadassah Medical Psychedelic: Filament reports compassionate use approval for psilocybin PremiumThe FlyPsychedelic: atai Life Sciences, Beckley Psytech report BPL-003 study results Clearmind Medicine announces IRB approval for Phase 1/2a trial for AUD Clearmind Medicine announces first participant ever dosed with CMND-100 PremiumThe FlyClearmind notes partnership with political firm to promote psychedelics Clearmind Medicine adds Tel Aviv Sourasky Medical Center to ongoing AUD trial Trump Trade: President said to weigh possible U.S. strike against Iran 
